The RAPID pathway is designed to accelerate access to certain FDA-designated Class II and Class III devices for people with Medicare coverage, CMS and FDA officials said. (Inna Knot/GettyImages) The ...
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results